Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Citizens (CIA) Cash & Equivalents (2016 - 2025)

Citizens has reported Cash & Equivalents over the past 16 years, most recently at $23.0 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $23.0 million for Q4 2025, down 21.51% from a year ago — trailing twelve months through Dec 2025 was $23.0 million (down 21.51% YoY), and the annual figure for FY2025 was $23.0 million, down 21.51%.
  • Cash & Equivalents for Q4 2025 was $23.0 million at Citizens, down from $23.1 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for CIA hit a ceiling of $32.4 million in Q3 2024 and a floor of $16.8 million in Q3 2023.
  • Median Cash & Equivalents over the past 5 years was $23.0 million (2022), compared with a mean of $23.8 million.
  • Biggest five-year swings in Cash & Equivalents: plummeted 44.22% in 2021 and later soared 92.92% in 2024.
  • Citizens' Cash & Equivalents stood at $27.3 million in 2021, then decreased by 15.83% to $23.0 million in 2022, then increased by 17.52% to $27.0 million in 2023, then rose by 8.42% to $29.3 million in 2024, then decreased by 21.51% to $23.0 million in 2025.
  • The last three reported values for Cash & Equivalents were $23.0 million (Q4 2025), $23.1 million (Q3 2025), and $22.7 million (Q2 2025) per Business Quant data.